<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Can J Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Can. J. Vet. Res</journal-id><journal-id journal-id-type="pmc-domain-id">133</journal-id><journal-id journal-id-type="pmc-domain">cjvetres</journal-id><journal-title-group><journal-title>Canadian Journal of Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0830-9000</issn><issn pub-type="epub">1928-9022</issn><publisher><publisher-name>Canadian Veterinary Medical Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6318821</article-id><article-id pub-id-type="pmcid-ver">PMC6318821.1</article-id><article-id pub-id-type="pmcaid">6318821</article-id><article-id pub-id-type="pmcaiid">6318821</article-id><article-id pub-id-type="pmid">30670904</article-id><article-id pub-id-type="publisher-id">cjvr_01_68</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Protective efficacy of an inactivated <italic toggle="yes">Brucella abortus</italic> vaccine candidate lysed by GI24 against brucellosis in Korean black goats</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="WK">Wong-Kyong</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moon</surname><given-names initials="JY">Ja-Young</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cho</surname><given-names initials="JS">Jeong-Sang</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ochirkhuyag</surname><given-names initials="E">Enkhsaikhan</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Akanda</surname><given-names initials="MR">Md Rashedunnabi</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="BY">Byung-Yong</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hur</surname><given-names initials="J">Jin</given-names></name></contrib><aff id="af1-cjvr_01_68">Veterinary Public Health, College of Veterinary Medicine, Chonbuk National University, Gobong-ro 79, Iksan, Jeollabuk-do, Republic of Korea (Kim, Moon, Cho, Ochirkhuyag, Hur); Veterinary Histology, College of Veterinary Medicine, Chonbuk National University, Gobong-ro 79, Iksan, Jeollabuk-do, Republic of Korea (Akanda, Park)</aff></contrib-group><author-notes><corresp id="c1-cjvr_01_68">Address all correspondence to Dr. Jin Hur; telephone: +82-63-850-0959; fax: +82-63-850-0910; e-mail: <email>hurjin@jbnu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2019</year></pub-date><volume>83</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">326812</issue-id><fpage>68</fpage><lpage>74</lpage><history><date date-type="received"><day>24</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>02</day><month>4</month><year>2018</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>01</day><month>07</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-07-01 00:21:11.373"><day>01</day><month>07</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>Copyright and/or publishing rights held by the Canadian Veterinary Medical Association</copyright-statement><copyright-year>2019</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cjvr_01_68.pdf"/><abstract><p>The efficacy of GI24-lysed <italic toggle="yes">Brucella abortus</italic> cells as a vaccine candidate against brucellosis in goats was evaluated on 2 groups of Korean black goats. Group A goats were immunized subcutaneously (SC) with sterile phosphate-buffered saline, whereas group B goats were immunized SC with approximately 3 &#215; 10<sup>9</sup> lysed <italic toggle="yes">B. abortus</italic> cells. Subcutaneous immunization with the lysed cells did not cause any negative impact on the overall clinical status, such as behavior and appetite, throughout the study period. The enzyme-linked immunosorbent assay (ELISA) optical densities values for <italic toggle="yes">B. abortus</italic> lipopolysaccharide in serum were considerably higher in group B than those in group A. Also, the levels of the cytokines interleukin 4 (IL-4), tumor necrosis factor-alpha (TNF-&#945;), and interferon gamma (IFN-&#947;) were significantly elevated in group B compared with those in group A. Following intraconjunctival challenge with <italic toggle="yes">B. abortus</italic> strain 544, the severity of brucellosis in terms of infection index and colonization of <italic toggle="yes">B. abortus</italic> in tissues was significantly lower in group B than in group A. The present study concluded that 3 of 5 goats immunized with GI24-lysed bacteria were completely protected against challenge. Future investigations are required to improve the protective efficacy offered by lysed <italic toggle="yes">B. abortus</italic> cells for practical applications in small ruminants.</p></abstract><trans-abstract xml:lang="fr"><title>R&#233;sum&#233;</title><p>L&#8217;efficacit&#233; de cellules lys&#233;es de <italic toggle="yes">Brucella abortus</italic> GI24 comme vaccin candidat contre la brucellose chez les ch&#232;vres a &#233;t&#233; &#233;valu&#233;e chez deux groupes de ch&#232;vres noires cor&#233;ennes. Les ch&#232;vres du groupe A ont &#233;t&#233; immunis&#233;es par voie sous-cutan&#233;e (SC) avec de la saline tamponn&#233;e st&#233;rile, alors que les ch&#232;vres du groupe B ont &#233;t&#233; immunis&#233;es SC avec environ 3 <italic toggle="yes">&#215;</italic> 10<sup>9</sup> cellules lys&#233;es de <italic toggle="yes">B. abortus.</italic> L&#8217;immunisation sous-cutan&#233;e avec les cellules lys&#233;es n&#8217;a pas eu d&#8217;impact n&#233;gatif sur l&#8217;&#233;tat clinique g&#233;n&#233;ral, tel que le comportement et l&#8217;app&#233;tit, tout au long de la p&#233;riode d&#8217;&#233;tude. Les valeurs de densit&#233; optique obtenues lors d&#8217;&#233;preuves immunoenzymatiques (ELISA) utilisant le lipopolysaccharide de <italic toggle="yes">B. abortus</italic> &#233;taient consid&#233;rablement plus &#233;lev&#233;es avec le s&#233;rum des animaux du groupe B que celui des animaux du groupe A. De plus, les niveaux des cytokines interleukine-4 (IL-4), du facteur-alpha n&#233;crosant de tumeur (TNF-&#945;), d&#8217;interf&#233;ron-gamma (IFN-&#947;) &#233;taient significativement plus &#233;lev&#233;s dans le groupe B comparativement au groupe A. Pour donner suite &#224; l&#8217;infection-d&#233;fi intra-conjonctivale avec la souche 544 de <italic toggle="yes">B. abortus,</italic> la s&#233;v&#233;rit&#233; de brucellose en termes d&#8217;index d&#8217;infection et de colonisation des tissus par <italic toggle="yes">B. abortus</italic> &#233;tait significativement moindre dans le groupe B que dans le groupe A. La pr&#233;sente &#233;tude a permis de conclure que 3 des 5 ch&#232;vres immunis&#233;es avec les bact&#233;ries GI24 lys&#233;es &#233;taient compl&#232;tement prot&#233;g&#233;es contre l&#8217;infection. Des &#233;tudes ult&#233;rieures sont requises pour am&#233;liorer l&#8217;efficacit&#233; protectrice offerte par les cellules lys&#233;es de <italic toggle="yes">B. abortus</italic> pour une application pratique chez les petits ruminants.</p><p>(Traduit par Docteur Serge Messier)</p></trans-abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>